-
★
EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated Share
(Hinzugefügt: 05.05.2021 um 10:30 Uhr)
https://www.ema.europa.eu/en/news/ema-starts-rolling-review-covid-19-vaccine-vero-cell-inactivated
-
★
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
(Hinzugefügt: 15.02.2021 um 08:55 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30987-7/fulltext
-
★
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
(Hinzugefügt: 04.02.2021 um 09:33 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30843-4/fulltext
-
A booster dose of an inactivated vaccine increases neutralizing antibodies and T cell responses against SARS-CoV-2
(Hinzugefügt: 25.11.2021 um 19:04 Uhr)
https://www.medrxiv.org/content/10.1101/2021.11.16.21266350v1
-
A RCT of a third dose CoronaVac or BNT162b2 vaccine in adults with two doses of CoronaVac
(Hinzugefügt: 05.11.2021 um 07:28 Uhr)
https://www.medrxiv.org/content/10.1101/2021.11.02.21265843v1
-
CoronaVac induces lower neutralising activity against variants of concern than natural infection
(Hinzugefügt: 15.09.2021 um 15:30 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00568-5/fulltext
-
Estimating the early impact of vaccination against COVID-19 on deaths among elderly people in Brazil: Analyses of routinely-collected data on vaccine coverage and mortality
(Hinzugefügt: 24.08.2021 um 16:50 Uhr)
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00316-3/fulltext
-
Effectiveness of Inactivated COVID-19 Vaccines Against COVID-19 Pneumonia and Severe Illness Caused by the B.1.617.2 (Delta) Variant: Evidence from an Outbreak in Guangdong, China
(Hinzugefügt: 24.08.2021 um 16:34 Uhr)
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3895639
-
Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study
(Hinzugefügt: 24.08.2021 um 15:16 Uhr)
https://www.bmj.com/content/374/bmj.n2015
-
China's Sinovac COVID-19 Vaccine Only 58% Effective Against COVID-19: Study
(Hinzugefügt: 06.08.2021 um 11:30 Uhr)
https://www.ibtimes.com/chinas-sinovac-covid-19-vaccine-only-58-effective-against-covid-19-study-3266622
-
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
(Hinzugefügt: 03.08.2021 um 09:17 Uhr)
https://www.nature.com/articles/s41591-021-01469-5
-
Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial
(Hinzugefügt: 27.07.2021 um 19:25 Uhr)
https://www.medrxiv.org/content/10.1101/2021.07.23.21261026v1
-
Antibodies from Sinovac's COVID-19 shot fade after about 6 months, booster helps - study
(Hinzugefügt: 27.07.2021 um 19:25 Uhr)
https://www.reuters.com/business/healthcare-pharmaceuticals/antibodies-sinovacs-covid-19-shot-fade-after-about-6-months-booster-helps-study-2021-07-26/
-
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
(Hinzugefügt: 20.07.2021 um 10:52 Uhr)
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00129-4/fulltext
-
SARS-CoV-2 variants of concern exhibit reduced sensitivity to live-virus neutralization in sera from CoronaVac vaccinees and naturally infected COVID-19 patients
(Hinzugefügt: 17.07.2021 um 13:15 Uhr)
https://www.medrxiv.org/content/10.1101/2021.07.10.21260232v2
-
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
(Hinzugefügt: 09.07.2021 um 18:24 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01429-X/fulltext
-
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
(Hinzugefügt: 09.07.2021 um 18:23 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMoa2107715
-
CoronaVac: Impfstoff aus China erzielt hohe Schutzwirkung in der Türkei und Chile
(Hinzugefügt: 09.07.2021 um 18:20 Uhr)
https://www.aerzteblatt.de/nachrichten/125463/CoronaVac-Impfstoff-aus-China-erzielt-hohe-Schutzwirkung-in-der-Tuerkei-und-Chile
-
Leaked memo raises Thai concern about Sinovac vaccine's efficacy
(Hinzugefügt: 07.07.2021 um 07:16 Uhr)
https://www.reuters.com/world/asia-pacific/leaked-memo-raises-thai-concern-about-sinovac-vaccines-efficacy-2021-07-05/
-
Covid-19 Killed 26 Indonesian Doctors in June—at Least 10 Had Taken China’s Sinovac Vaccine
(Hinzugefügt: 30.06.2021 um 15:08 Uhr)
https://www.wsj.com/articles/covid-19-killed-26-indonesian-doctors-in-juneat-least-10-had-taken-chinas-sinovac-vaccine-11624769885
-
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial
(Hinzugefügt: 30.06.2021 um 14:43 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00319-4/fulltext
-
BioNTech shots have stronger antibody response than Sinovac, Hong Kong study shows - SCMP
(Hinzugefügt: 21.06.2021 um 13:15 Uhr)
https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-shots-have-stronger-antibody-response-than-sinovac-hong-kong-study-2021-06-19/
-
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
(Hinzugefügt: 06.06.2021 um 17:06 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2780562
-
Immunization of Serrana´s population with Butantan´s vaccine has a high decrease of 80% cases and 95% in deaths by COVID-19
(Hinzugefügt: 06.06.2021 um 14:57 Uhr)
https://butantan.gov.br/noticias/immunization-of-serrana%C2%B4s-population-with-butantan%C2%B4s-vaccine-has-a-high-decrease-of-80-cases-and-95-in-deaths-by-covid-19
-
WHO lässt Impfstoff von Sinovac zu
(Hinzugefügt: 06.06.2021 um 14:55 Uhr)
https://www.n-tv.de/wissen/WHO-laesst-Impfstoff-von-Sinovac-zu-article22590473.html
-
WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations
(Hinzugefügt: 06.06.2021 um 14:54 Uhr)
https://www.who.int/news/item/01-06-2021-who-validates-sinovac-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations
-
Sinovac’s COVID-19 vaccine gains China nod for emergency use in kids, adolescents
(Hinzugefügt: 06.06.2021 um 14:32 Uhr)
https://www.reuters.com/world/china/sinovacs-covid-19-vaccine-gains-china-approval-emergency-use-children-2021-06-05/
-
Antibody Response to CoronaVac Vaccine in Indonesian COVID-19 Survivor
(Hinzugefügt: 31.05.2021 um 17:51 Uhr)
https://www.medrxiv.org/content/10.1101/2021.05.28.21254613v1
-
Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac
(Hinzugefügt: 28.05.2021 um 08:13 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00287-5/fulltext
-
Indonesia finds China’s Sinovac 100% effective against death in 28-day real world study
(Hinzugefügt: 13.05.2021 um 17:28 Uhr)
https://theprint.in/world/indonesia-finds-chinas-sinovac-100-effective-against-death-in-28-day-real-world-study/656817/
-
Alfie: "Preliminary" data from GACH suggest "similar" effects of Sinovac and Pfizer to reduce mortality from covid-19
(Hinzugefügt: 07.05.2021 um 06:30 Uhr)
https://www.sarandi690.com.uy/2021/05/06/alfie-datos-preliminares-del-gach-sugieren-efectos-similares-de-sinovac-y-pfizer-para-reducir-mortalidad-por-covid-19/
-
China’s COVID vaccines are going global — but questions remain
(Hinzugefügt: 05.05.2021 um 10:34 Uhr)
https://www.nature.com/articles/d41586-021-01146-0
-
WHO: Evidence Assessment: Sinovac/CoronaVac COVID-19 vaccine
(Hinzugefügt: 04.05.2021 um 05:34 Uhr)
https://cdn.who.int/media/docs/default-source/immunization/sage/2021/april/5_sage29apr2021_critical-evidence_sinovac.pdf
-
In Brazil, alarm over no-shows for second Covid vaccine dose
(Hinzugefügt: 29.04.2021 um 07:45 Uhr)
https://www.nbcnews.com/news/latino/brazil-alarm-no-shows-second-covid-vaccine-dose-rcna753
-
Thailand sticks with Sinovac vaccine after cases of 'stroke-like' side effects
(Hinzugefügt: 21.04.2021 um 14:05 Uhr)
https://www.reuters.com/world/asia-pacific/thailand-sticks-with-sinovac-vaccine-after-cases-stroke-like-side-effects-2021-04-21/
-
Performance of vaccination with CoronaVac in a cohort of healthcare workers (HCW) - preliminary report
(Hinzugefügt: 16.04.2021 um 12:22 Uhr)
https://www.medrxiv.org/content/10.1101/2021.04.12.21255308v1
-
In clinical and real world trials, China’s Sinovac underperforms
(Hinzugefügt: 16.04.2021 um 12:15 Uhr)
https://www.economist.com/graphic-detail/2021/04/15/in-clinical-and-real-world-trials-chinas-sinovac-underperforms
-
SARS-CoV-2: Chinesischer Totimpfstoff schützt offenbar auch vor brasilianischer Variante
(Hinzugefügt: 13.04.2021 um 11:14 Uhr)
https://www.aerzteblatt.de/nachrichten/122884/SARS-CoV-2-Chinesischer-Totimpfstoff-schuetzt-offenbar-auch-vor-brasilianischer-Variante
-
Sinovac vaccine effective against virus variants in Brazil; efficacy rises if injection interval is more than 21 days
(Hinzugefügt: 13.04.2021 um 11:04 Uhr)
https://www.globaltimes.cn/page/202104/1220886.shtml
-
COVID-19 Vaccine Efficacy Questions
(Hinzugefügt: 13.04.2021 um 10:52 Uhr)
https://blogs.sciencemag.org/pipeline/archives/2021/04/12/vaccine-efficacy-questions
-
Top Chinese official admits vaccines have low effectiveness
(Hinzugefügt: 12.04.2021 um 18:06 Uhr)
https://abcnews.go.com/Health/wireStory/official-chinese-vaccines-effectiveness-low-77002863
-
Chinese COVID-19 vaccine maintains protection in variant-plagued Brazil
(Hinzugefügt: 10.04.2021 um 05:34 Uhr)
https://www.sciencemag.org/news/2021/04/chinese-covid-19-vaccine-maintains-protection-variant-plagued-brazil
-
Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study
(Hinzugefügt: 09.04.2021 um 06:11 Uhr)
https://www.medrxiv.org/content/10.1101/2021.04.07.21255081v1
-
Incidência da Covid-19 em funcionários do HC de SP vacinados com a CoronaVac foi de 50,7% a 73,8% menor do que na população, diz USP
(Hinzugefügt: 07.04.2021 um 17:28 Uhr)
https://g1.globo.com/sp/sao-paulo/noticia/2021/04/07/incidencia-da-covid-19-em-funcionarios-do-hc-de-sp-vacinados-com-a-coronavac-foi-de-507percent-a-738percent-menor-do-que-na-populacao-diz-usp.ghtml
-
Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
(Hinzugefügt: 07.04.2021 um 07:05 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMc2103022
-
Interim Report: Safety And Immunogenicity Of An Inactivated Vaccine Against Sars-Cov-2 In Healthy Chilean Adults In A Phase 3 Clinical Trial
(Hinzugefügt: 02.04.2021 um 04:34 Uhr)
https://www.medrxiv.org/content/10.1101/2021.03.31.21254494v1
-
Sinopharm, Sinovac COVID-19 vaccine data show efficacy: WHO
(Hinzugefügt: 01.04.2021 um 05:38 Uhr)
https://www.reuters.com/article/us-health-coronavirus-who-china-vaccines-idUSKBN2BN1K8
-
China’s vaccine diplomacy stumbles as clinical trial data remains absent
(Hinzugefügt: 24.03.2021 um 08:50 Uhr)
https://www.washingtonpost.com/world/asia_pacific/china-coronavirus-singapore-data/2021/03/23/7a0582ca-8afc-11eb-a33e-da28941cb9ac_story.html
-
Sinovac says its vaccine is safe for children as young as 3
(Hinzugefügt: 23.03.2021 um 09:56 Uhr)
https://apnews.com/article/clinical-trials-coronavirus-pandemic-china-coronavirus-vaccine-taiwan-fb94301994153e07f8c5ca259a996607
-
Preliminary studies carried out by Butantan in vaccinated people demonstrate that Coronavac is able to neutralize variants of the new coronavirus
(Hinzugefügt: 11.03.2021 um 09:03 Uhr)
https://butantan.gov.br/noticias/estudos-preliminares-realizados-pelo-butantan-em-pessoas-vacinadas-demonstram-que-a-coronavac-e-capaz-de-neutralizar-variantes-do-novo-coronavirus
-
Butantan says that CoronaVac is effective against the three variants of the coronavirus circulating in the country
(Hinzugefügt: 11.03.2021 um 08:59 Uhr)
https://g1.globo.com/sp/sao-paulo/noticia/2021/03/10/butantan-diz-que-coronavac-e-eficaz-contra-as-tres-variantes-do-coronavirus-em-circulacao-no-pais.ghtml
-
Sinovac's COVID-19 shot is 83% effective, not 91%, Turkey says
(Hinzugefügt: 04.03.2021 um 15:15 Uhr)
https://asia.nikkei.com/Spotlight/Coronavirus/Sinovac-s-COVID-19-shot-is-83-effective-not-91-Turkey-says
-
Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use
(Hinzugefügt: 03.03.2021 um 08:29 Uhr)
https://www.reuters.com/article/us-health-coronavirus-malaysia-idUSKBN2AU19V
-
Chinese vaccines sweep much of the world, despite concerns
(Hinzugefügt: 03.03.2021 um 08:27 Uhr)
https://abcnews.go.com/Health/wireStory/chinese-vaccines-sweep-world-concerns-76195475
-
CoronaVac Vaccine By Sinovac : Your Questions Answered!
(Hinzugefügt: 01.03.2021 um 08:40 Uhr)
https://www.techarp.com/science/coronavac-vaccine-sinovac-faq/
-
Sinovac vaccine works on UK, South African variants - Brazil institute
(Hinzugefügt: 18.02.2021 um 08:15 Uhr)
https://www.reuters.com/article/us-health-coronavirus-brazil-idUSKBN2AH2H0
-
Single-Cell Sequencing and Immune Function Assays of Peripheral Blood Samples Demonstrate Positive Responses of an Inactivated SARS-CoV-2 Vaccine
(Hinzugefügt: 15.02.2021 um 08:53 Uhr)
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3774153
-
Government of São Paulo Will Immunize The Entire Vaccinable Population of a Small Town to Assess The Effect on Covid
(Hinzugefügt: 10.02.2021 um 09:58 Uhr)
https://www1.folha.uol.com.br/internacional/en/scienceandhealth/2021/02/government-of-sao-paulo-will-immunize-the-entire-vaccinable-population-of-a-small-town-to-assess-the-effect-on-covid.shtml
-
SARS-CoV-2: Sinovac verkündet Ergebnisse aus Phase-3-Studie
(Hinzugefügt: 10.02.2021 um 09:29 Uhr)
https://www.aerzteblatt.de/nachrichten/120982/SARS-CoV-2-Sinovac-verkuendet-Ergebnisse-aus-Phase-3-Studie
-
Sinovac Announces Phase III Results of Its COVID-19 Vaccine
(Hinzugefügt: 06.02.2021 um 18:42 Uhr)
http://www.sinovac.com/?optionid=754&auto_id=922
-
Sinovac applies for conditional approval of COVID-19 vaccine in China
(Hinzugefügt: 06.02.2021 um 09:41 Uhr)
https://asia.nikkei.com/Spotlight/Caixin/Sinovac-applies-for-conditional-approval-of-COVID-19-vaccine-in-China
-
3 Impfstoffe aus China drängen auf weltweiten Einsatz
(Hinzugefügt: 04.02.2021 um 09:24 Uhr)
https://www.aerzteblatt.de/nachrichten/120839/3-Impfstoffe-aus-China-draengen-auf-weltweiten-Einsatz
-
China COVID vaccine reports mixed results — what does that mean for the pandemic?
(Hinzugefügt: 29.01.2021 um 10:29 Uhr)
https://www.nature.com/articles/d41586-021-00094-z
-
Raging virus, few shots. How Brazil missed its chance to secure COVID-19 vaccines
(Hinzugefügt: 28.01.2021 um 16:35 Uhr)
https://www.reuters.com/article/us-health-coronavirus-brazil-vaccines-in-idUSKBN29W141
-
Johnson and Johnson, SinoVac and More
(Hinzugefügt: 15.01.2021 um 07:01 Uhr)
https://blogs.sciencemag.org/pipeline/archives/2021/01/14/johnson-and-johnson-sinovac-and-more
-
Wariness in Indonesia as Chinese Sinovac COVID-19 jabs start
(Hinzugefügt: 15.01.2021 um 06:59 Uhr)
https://www.reuters.com/article/us-health-coronavirus-indonesia-healthca/wariness-in-indonesia-as-chinese-sinovac-covid-19-jabs-start-idUSKBN29I0T1
-
Coronavirus: Turkey approves China’s Sinovac vaccine for emergency use
(Hinzugefügt: 14.01.2021 um 04:52 Uhr)
https://www.scmp.com/news/world/middle-east/article/3117633/coronavirus-turkey-approves-chinas-sinovac-vaccine-emergency
-
China's Sinovac defends COVID-19 vaccine after disappointing Brazil data
(Hinzugefügt: 13.01.2021 um 19:27 Uhr)
https://www.reuters.com/article/us-health-coronavirus-malaysia-idUSKBN29I0ZB?taid=5ffef4b44156da0001be28b7&utm_campaign=trueAnthem:+Trending+Content&utm_medium=trueAnthem&utm_source=twitter
-
Singapore will review Sinovac Covid-19 vaccine carefully before possible roll-out: Gan Kim Yong
(Hinzugefügt: 13.01.2021 um 11:46 Uhr)
https://www.straitstimes.com/singapore/covid-19-comprehensive-review-for-sinovac-vaccine-before-possible-roll-out-in-singapore
-
China's Sinovac vaccine has "general efficacy" of 50.4% in Brazil trials, says Butantan
(Hinzugefügt: 12.01.2021 um 20:38 Uhr)
https://www.reuters.com/article/healthcoronavirus-brazil-coronavirus/chinas-sinovac-vaccine-has-general-efficacy-of-50-4-in-brazil-trials-says-butantan-idUSE5N2HA01G
-
Coronavirus: Brazil finds China’s Sinovac vaccine to be less effective than previous data shows
(Hinzugefügt: 12.01.2021 um 20:37 Uhr)
https://www.scmp.com/news/china/science/article/3117471/coronavirus-brazil-reports-more-modest-504-cent-efficacy-chinas
-
Sinovac's vaccine general efficacy less than 60% in Brazil trial - report
(Hinzugefügt: 12.01.2021 um 08:02 Uhr)
https://www.reuters.com/article/us-health-coronavirus-brazil-sinovac-idUSKBN29G2MV?taid=5ffd06308844f30001748c17&utm_campaign=trueAnthem:+Trending+Content&utm_medium=trueAnthem&utm_source=twitter
-
Indonesia says China’s Sinovac vaccine 65.3 per cent effective, grants emergency approval
(Hinzugefügt: 12.01.2021 um 08:01 Uhr)
https://www.scmp.com/news/asia/australasia/article/3117159/coronavirus-brisbane-lifts-lockdown-japan-conduct-large-scale
-
Sinovac’s Vaccine Approved by Indonesia for Emergency Use
(Hinzugefügt: 11.01.2021 um 18:56 Uhr)
https://www.bloomberg.com/news/articles/2021-01-11/sinovac-s-covid-vaccine-approved-by-indonesia-for-emergency-use
-
Sinovac, AstraZeneca seek vaccine approval in Brazil
(Hinzugefügt: 10.01.2021 um 19:46 Uhr)
https://medicalxpress.com/news/2021-01-sinovac-astrazeneca-vaccine-brazil.html
-
Sinovac vaccine 78% effective in Brazil trial, experts call for more details
(Hinzugefügt: 08.01.2021 um 09:41 Uhr)
https://www.reuters.com/article/health-coronavirus-brazil-sinovac/sinovacs-covid-19-vaccine-78-effective-in-late-stage-trials-in-brazil-source-idINKBN29C1W5?edition-redirect=in
-
Turkey and Brazil Say Chinese Vaccine Effective, With Sparse Supporting Data
(Hinzugefügt: 31.12.2020 um 11:30 Uhr)
https://www.nytimes.com/2020/12/25/health/turkey-brazil-sinovac-coronavirus-vaccine.html